Page last updated: 2024-08-16

canrenoic acid and Cardiac Remodeling, Ventricular

canrenoic acid has been researched along with Cardiac Remodeling, Ventricular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blackman, D; Bulluck, H; Davies, J; Fröhlich, GM; Gamma, R; Garg, P; Greenwood, JP; Hausenloy, DJ; Mathur, A; Mohdnazri, S; Moon, JC; Nicholas, JM; Sirker, A	1

Trials

1 trial(s) available for canrenoic acid and Cardiac Remodeling, Ventricular

Article	Year
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial. American heart journal, 2019, Volume: 211 Topics: Aged; Canrenoic Acid; Cardiac Imaging Techniques; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Pilot Projects; Proof of Concept Study; Spironolactone; ST Elevation Myocardial Infarction; Ventricular Remodeling	2019

Article

Year

Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.

American heart journal, 2019, Volume: 211

Topics: Aged; Canrenoic Acid; Cardiac Imaging Techniques; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Pilot Projects; Proof of Concept Study; Spironolactone; ST Elevation Myocardial Infarction; Ventricular Remodeling

2019